Please login to the form below

Not currently logged in
Email:
Password:

access

This page shows the latest access news and features for those working in and with pharma, biotech and healthcare.

Hancock's 'Tech Revolution' for NHS to be limited by budgets

Hancock's 'Tech Revolution' for NHS to be limited by budgets

Access to real-time data will underpin digital services in the NHS, backed with plans to introduce minimum technical standards that digital services and IT systems in the NHS will have ... Connected systems ensure that clinicians have immediate access to

Latest news

More from news
Approximately 213 fully matching, plus 1,192 partially matching documents found.

Latest Intelligence

  • Joint working that works Joint working that works

    Collaboration gives industry access to invaluable strategic insights, and with better understanding of their NHS customers and stakeholders, companies are better able to align corporate objectives with the public health agenda,

  • The case for a second Brexit referendum: “We need the informed consent of the people” The case for a second Brexit referendum: “We need the informed consent of the people”

    As many in the pharma industry know, the EEA allows Norway, Iceland and Liechtenstein to be part of the EMA and gain access to the new medicines at the same time. ... May and her cabinet looked to address concerns about medicines access in the Chequers

  • KAM 2.0 KAM 2.0

    Cross-functional buy-in is essential – KAMs should tap into medical, marketing and market access, as well as sales – but again this is a mindset and process shift for teams used

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    Despite our success in partnering with hospitals and government to improve access to new medicines, there remains a significant unmet medical need across China. ... I think China is evolving all the time. The changing demographics of the population and

  • Stakeholder dialogue in Europe’s adaptive pathways pilot Stakeholder dialogue in Europe’s adaptive pathways pilot

    The European Medicines Agency (EMA) has worked for several years to speed patient access to new medicines. ... Evidence suggests that medicines using the resulting accelerated access initiatives experience variable reimbursement outcomes due to

More from intelligence
Approximately 66 fully matching, plus 406 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 154 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 36 fully matching, plus 471 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics